Zhou J - Search Results

1

Exosomes as Drug Carriers in Anti-Cancer Therapy.

Chen L, Wang L, Zhu L, Xu Z, Liu Y, Li Z, Zhou J, Luo F. Chen L, et al. Among authors: zhou j. Front Cell Dev Biol. 2022 Jan 26;10:728616. doi: 10.3389/fcell.2022.728616. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35155421 Free PMC article. Review.

2

Orthotopic transplantation of cryopreserved mouse ovaries and gonadotrophin releasing hormone analogues in the restoration of function following chemotherapy-induced ovarian damage.

Li Q, Szatmary P, Liu Y, Ding Z, Zhou J, Sun Y, Luo F, Wang Y, Zhu J. Li Q, et al. Among authors: zhou j. PLoS One. 2015 Mar 26;10(3):e0120736. doi: 10.1371/journal.pone.0120736. eCollection 2015. PLoS One. 2015. PMID: 25811681 Free PMC article.

3

Bisphosphonates enhance EGFR-TKIs efficacy in advanced NSCLC patients with EGFR activating mutation: A retrospective study.

Huang CY, Wang L, Feng CJ, Yu P, Cai XH, Yao WX, Xu Y, Liu XK, Zhu WJ, Wang Y, Zhou J, Lu Y, Wang YS. Huang CY, et al. Among authors: zhou j. Oncotarget. 2016 Oct 11;7(41):66480-66490. doi: 10.18632/oncotarget.5515. Oncotarget. 2016. PMID: 26624882 Free PMC article.

4

Quercetin reduces cyclin D1 activity and induces G1 phase arrest in HepG2 cells.

Zhou J, Li LU, Fang LI, Xie H, Yao W, Zhou X, Xiong Z, Wang LI, Li Z, Luo F. Zhou J, et al. Among authors: zhou x. Oncol Lett. 2016 Jul;12(1):516-522. doi: 10.3892/ol.2016.4639. Epub 2016 May 27. Oncol Lett. 2016. PMID: 27347174 Free PMC article.

5

E. coli diversity: low in colorectal cancer.

Tang L, Zhou YJ, Zhu S, Liang GD, Zhuang H, Zhao MF, Chang XY, Li HN, Liu Z, Guo ZR, Liu WQ, He X, Wang CX, Zhao DD, Li JJ, Mu XQ, Yao BQ, Li X, Li YG, Duo LB, Wang L, Johnston RN, Zhou J, Zhao JB, Liu GR, Liu SL. Tang L, et al. Among authors: zhou j, zhou yj. BMC Med Genomics. 2020 Apr 6;13(1):59. doi: 10.1186/s12920-020-0704-3. BMC Med Genomics. 2020. PMID: 32252754 Free PMC article.

6

miRNA-101 Suppresses Epithelial-to-Mesenchymal Transition by Targeting HMGA2 in Pancreatic Cancer Cells.

Jiang W, Gu W, Qiu R, He S, Shen C, Wu Y, Zhang J, Zhou J, Guo Y, Wan D, Li Z, Deng J, Zeng L, Tang J, Zhou J, Zhi Q, Deng X. Jiang W, et al. Among authors: zhou j. Anticancer Agents Med Chem. 2016;16(4):432-9. doi: 10.2174/1871520615666150507122142. Anticancer Agents Med Chem. 2016. PMID: 25968875

7

Investigation of the anti-cancer effect of quercetin on HepG2 cells in vivo.

Zhou J, Fang L, Liao J, Li L, Yao W, Xiong Z, Zhou X. Zhou J, et al. Among authors: zhou x. PLoS One. 2017 Mar 6;12(3):e0172838. doi: 10.1371/journal.pone.0172838. eCollection 2017. PLoS One. 2017. PMID: 28264020 Free PMC article.

8

Single-agent arsenic trioxide in the treatment of children with newly diagnosed acute promyelocytic leukemia.

Zhou J, Zhang Y, Li J, Li X, Hou J, Zhao Y, Liu X, Han X, Hu L, Wang S, Zhao Y, Zhang Y, Fan S, Lv C, Li L, Zhu L. Zhou J, et al. Blood. 2010 Mar 4;115(9):1697-702. doi: 10.1182/blood-2009-07-230805. Epub 2009 Dec 22. Blood. 2010. PMID: 20029047 Free article. Clinical Trial.

9

Canagliflozin Ameliorates NLRP3 Inflammasome-Mediated Inflammation Through Inhibiting NF-κB Signaling and Upregulating Bif-1.

Niu Y, Zhang Y, Zhang W, Lu J, Chen Y, Hao W, Zhou J, Wang L, Xie W. Niu Y, et al. Among authors: zhou j. Front Pharmacol. 2022 Mar 28;13:820541. doi: 10.3389/fphar.2022.820541. eCollection 2022. Front Pharmacol. 2022. PMID: 35418866 Free PMC article.

10

Prospects of the Use of Cell Therapy to Induce Immune Tolerance.

Wang Z, Liu X, Cao F, Bellanti JA, Zhou J, Zheng SG. Wang Z, et al. Among authors: zhou j. Front Immunol. 2020 May 12;11:792. doi: 10.3389/fimmu.2020.00792. eCollection 2020. Front Immunol. 2020. PMID: 32477335 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

50,777 results

Search Page